03:44 PM EST - Amorfix Life Sciences : announced its operational and financial results for the first quarter ended June 30, 2011. For the three months ended June 30, 2011 the Company reported a net loss from operations of $529,484 ($0.01 per share) compared to net loss of $1,673,581 ($0.03 per share) for the three months ended June 30, 2010. For the three months ended June 30, 2011 revenue for services and sales was $32,862 as compared to $23,773 for the three months ended June 30, 2010. Amorfix Life Sciences
shares T.AMF are trading down $0.005 at $0.20.
